MeiraGTx Holdings plc (MGTX) Fair Value 2026

MGTX · Biotechnology ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.0 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-08-28, MeiraGTx Holdings plc (MGTX) trades at $13.82, versus a $6.75 median fair value across its 2 active models — 51.2% below the current price. QOC: 7.0/10. Value Trap Risk: 24/100 (SAFE). 2/13 models active.

Key Facts

Ticker
MGTX
Price
$13.82
Quality Score
7.0/10
Value Trap Risk
24/100
Models Active
2/13
Last Updated
Strength: 2 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is MeiraGTx Holdings plc (MGTX) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, MeiraGTx Holdings plc (MGTX) appears overvalued as of : the median of 2 independent fair value estimates is $6.75, 51.2% below the current price of $13.82. Estimates range from $1.78 to $11.72. MGTX scores 7.0/10 on fundamental quality and 24/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. MGTX’s -51.2% gap is wider than that market norm, and the Biotechnology sector median is -64.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy MeiraGTx Holdings plc Stock in 2026? →

What Fair Value Does Each Model Give MGTX?

2 Intrinsic Value Models vs. Current Price ($13.82)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $11.72 -15.2%
Relative · Low Conviction
 $1.78 -87.1%

All Models Active

All 2 models are displayed above.

What Is MeiraGTx Holdings plc (MGTX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, MeiraGTx Holdings plc's intrinsic value is estimated at $6.75. Trading at its current price of $13.82, the valuation engine raises significant caution: 2 of 2 models flag downside risk, projecting a median implied return of -51.2%. Model dispersion is worth noting: ML-RIV targets $11.72 (-15.2%), versus Regime Cross at $1.78 (-87.1%). This +72.0% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About MGTX?

2 of 13 models are currently active for MGTX. All 2 active models suggest the stock trades above fair value. Taken together, their median fair value for MGTX is $6.75 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does MGTX Rank in Biotechnology?

Among 625 Biotechnology stocks, MGTX ranks #47 by Quality of Company score. CirclFi's QOC score of 7.0/10 evaluates 32 fundamental signals. A score of 7.0 indicates above-average quality.

See all Most Undervalued Biotechnology Stocks →

The Biotechnology sector introduces analytical considerations specific to biotechnology enterprise businesses. For MeiraGTx Holdings plc, metrics like R&D burn rate provide important context that general-purpose valuation models may underweight.

Is MGTX a Value Trap?

CirclFi's Value Trap algorithm assigns MGTX a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for MeiraGTx Holdings plc. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, MeiraGTx Holdings plc scores 7.0 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +72.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MGTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MGTX's 2 active models, average confidence is 34%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy MeiraGTx Holdings plc Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

11 related Biotechnology stocks with 13-model coverage

SEERSeer, Inc.QOC 7.0ANABAnaptysBio, Inc.QOC 7.0MRNAModerna, Inc.QOC 7.0PRTAProthena Corporation plcQOC 7.0URGNUroGen Pharma Ltd.QOC 7.1ADAGAdagene Inc.QOC 7.0ACETAdicet Bio, Inc.QOC 5.6MPLTMapLight Therapeutics, Inc.QOC 4.8CNTNCanton Strategic Holdings, Inc.QOC 4.2EXELExelixis, Inc.QOC 9.6INCYIncyte CorporationQOC 9.5

Read investment analysis: SEER · ANAB · MRNA · PRTA · URGN · ADAG · ACET · MPLT · CNTN · EXEL · INCY

Which Other Stocks Have a Similar Quality Score to MGTX?

6 companies across all industries closest to MGTX’s Quality of Company score of 7.0/10.

FLGTFulgent Genetics, Inc.QOC 7.0OCCOptical Cable CorporationQOC 7.0CANCanaan Inc.QOC 7.0MEIMethode Electronics, Inc.QOC 7.0BSCLBILI Social International, Inc.QOC 7.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: FLGT · OCC · CAN · MEI · BSCL · NVDA

Where Does MGTX Sit in CirclFi's Biotechnology Rankings?

MGTX is ranked against every other Biotechnology stock CirclFi covers in each of these screens.

See all Biotechnology stocks ranked →

What Else Do Investors Ask About MeiraGTx Holdings plc’s Valuation?

What is MeiraGTx Holdings plc's intrinsic value in 2026?

CirclFi puts MeiraGTx Holdings plc (MGTX)'s intrinsic value at $6.75 — the median of 2 independent model estimates as of 2026-08-28, ranging from $1.78 to $11.72. The Quality of Company score is 7.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MGTX overvalued or undervalued right now?

At $13.82, 0 of 2 active models suggest MGTX may be undervalued, while 2 indicate potential overvaluation. The median of all 2 fair value estimates is $6.75, 51.2% below the current price of $13.82 — a consensus view that MGTX is overvalued. The assessment depends on which methodology best fits MeiraGTx Holdings plc's business model in Biotechnology.

What does a Quality of Company score of 7.0 mean for MGTX?

MeiraGTx Holdings plc's QOC of 7.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on MGTX?

CirclFi analyzes MGTX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is MGTX a value trap in 2026?

MeiraGTx Holdings plc's Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, MeiraGTx Holdings plc (MGTX) has a median fair value of $6.75 — 51.2% below the current price of $13.82 — as of 2026-08-28.” Source: circlfi.com/stock/MGTX/ · Methodology
Primary sources for this MGTX valuation
  • Financial statements: MeiraGTx Holdings plc 10-K and 10-Q filings on SEC EDGAR (CIK 0001735438) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for MGTX as of ; valuations recomputed .